| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1034161344 |
| P356 | DOI | 10.1186/S12961-015-0011-1 |
| P932 | PMC publication ID | 4424515 |
| P698 | PubMed publication ID | 25928535 |
| P5875 | ResearchGate publication ID | 275666359 |
| P50 | author | Mireille Goetghebeur | Q96947898 |
| P2093 | author name string | Christine Kriza | |
| Peter Kolominsky-Rabas | |||
| Philip Wahlster | |||
| National Leading-Edge Cluster Medical Technologies ‘Medical Valley EMN’ | |||
| Sandra Schaller | |||
| P2860 | cites work | Chronic monitoring of pulmonary artery pressure in patients with severe heart failure: multicentre experience of the monitoring Pulmonary Artery Pressure by Implantable device Responding to Ultrasonic Signal (PAPIRUS) II study | Q61651434 |
| Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: a multicenter, 12-month follow-up study of patients with chronic heart failure | Q74119819 | ||
| One-year mortality among unselected outpatients with heart failure | Q78554641 | ||
| Stakeholder involvement in expensive drug recommendation decisions: an international perspective | Q83191879 | ||
| Developing medical device technologies from users' perspectives: a theoretical framework for involving users in the development process | Q84759551 | ||
| A pilot study of multicriteria decision analysis for valuing orphan medicines. | Q48119113 | ||
| Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal | Q48572824 | ||
| Numbers can be worth a thousand pictures: individual differences in understanding graphical and numerical representations of health-related information. | Q50790591 | ||
| Multicriteria decision analysis for including health interventions in the universal health coverage benefit package in Thailand. | Q50909707 | ||
| Social values and health priority setting in Germany. | Q50923281 | ||
| Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. | Q51550980 | ||
| Optimal number of response categories in rating scales: reliability, validity, discriminating power, and respondent preferences. | Q52921113 | ||
| Social values and health policy: a new international research programme. | Q53126206 | ||
| Cost issues in new disease-modifying treatments for advanced cancer: in-depth interviews with physicians. | Q53185084 | ||
| Why do single event probabilities confuse patients? | Q53443715 | ||
| The ethics of accountability in managed care reform | Q56910417 | ||
| Selecting medical devices and materials for development in Korea: the analytic hierarchy process approach | Q57214905 | ||
| Essential components of public health evidence reviews: capturing intervention complexity, implementation, economics and equity | Q57382085 | ||
| Multi-criteria decision analysis to prioritize health interventions: Capitalizing on first experiences | Q58476451 | ||
| Priority setting using multiple criteria: should a lung health programme be implemented in Nepal? | Q58476484 | ||
| ??? | Q28267062 | ||
| Overview of the 2011 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee Meeting on the CardioMEMS Champion Heart Failure Monitoring System | Q27008839 | ||
| Telemedicine and cardiac implants: what is the benefit? | Q27009758 | ||
| How long and how well: oncologists' attitudes toward the relative value of life-prolonging v. quality of life-enhancing treatments | Q30226892 | ||
| The four principles: can they be measured and do they predict ethical decision making? | Q31061788 | ||
| Evidence and Value: Impact on DEcisionMaking--the EVIDEM framework and potential applications | Q33395099 | ||
| Combining multicriteria decision analysis, ethics and health technology assessment: applying the EVIDEM decision-making framework to growth hormone for Turner syndrome patients | Q33797377 | ||
| Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada | Q34086884 | ||
| What do patients and the public want from primary care? | Q34137312 | ||
| Multi-criteria clinical decision support: A primer on the use of multiple criteria decision making methods to promote evidence-based, patient-centered healthcare | Q34629519 | ||
| Medicines and the media: news reports of medicines recommended for government reimbursement in Australia. | Q34728746 | ||
| Priority setting of health interventions: the need for multi-criteria decision analysis | Q35017485 | ||
| Multi-criteria decision analysis for setting priorities on HIV/AIDS interventions in Thailand | Q35847949 | ||
| Field testing of a multicriteria decision analysis (MCDA) framework for coverage of a screening test for cervical cancer in South Africa | Q35898829 | ||
| Cognitive Processes in Decisions Under Risk are not the Same as in Decisions Under Uncertainty | Q36090070 | ||
| Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments? | Q36639084 | ||
| Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives | Q37210350 | ||
| In a survey, marked inconsistency in how oncologists judged value of high-cost cancer drugs in relation to gains in survival | Q37289756 | ||
| Demands for 'off-licence' access to trastuzumab (Herceptin): content analysis of UK newspaper articles | Q37332662 | ||
| Patient relevant endpoints in oncology: current issues in the context of early benefit assessment in Germany. | Q37513062 | ||
| Severity of illness and priority setting in healthcare: a review of the literature. | Q37588249 | ||
| Good judgments do not require complex cognition | Q37604201 | ||
| The Public Health Responsibility Deal: how should such a complex public health policy be evaluated? | Q38124023 | ||
| Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure | Q38375639 | ||
| Early benefit assessment of pharmaceuticals in Germany: manufacturers' expectations versus the Federal Joint Committee's decisions | Q39140889 | ||
| Disease management: remote monitoring in heart failure patients with implantable defibrillators, resynchronization devices, and haemodynamic monitors | Q39403892 | ||
| Balancing Equity and Efficiency in Health Priorities in Ghana: The Use of Multicriteria Decision Analysis | Q39963184 | ||
| Accountability for reasonableness | Q42769474 | ||
| Implementation of EUnetHTA core Model® in Lombardia: the VTS framework. | Q43894085 | ||
| An application of a proposed framework for formulary listing in low-income countries: the case of Côte d'Ivoire | Q43899167 | ||
| Which criteria are considered in healthcare decisions? Insights from an international survey of policy and clinical decision makers | Q44234115 | ||
| Population of Polish patients participating in the Heart Failure Pilot Survey (ESC-HF Pilot). | Q44669648 | ||
| Towards a multi-criteria approach for priority setting: An application to ghana | Q46954952 | ||
| The use of multi-criteria decision analysis weight elicitation techniques in patients with mild cognitive impairment: a pilot study | Q47240073 | ||
| Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. | Q47845346 | ||
| Comparison of a radiofrequency-based wireless pressure sensor to swan-ganz catheter and echocardiography for ambulatory assessment of pulmonary artery pressure in heart failure | Q48011867 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 24 | |
| P577 | publication date | 2015-04-28 | |
| P1433 | published in | Health Research Policy and Systems | Q15751858 |
| P1476 | title | Exploring the perspectives and preferences for HTA across German healthcare stakeholders using a multi-criteria assessment of a pulmonary heart sensor as a case study | |
| P478 | volume | 13 |
| Q38653139 | AN INTEGRATED PERSPECTIVE ON THE ASSESSMENT OF TECHNOLOGIES: INTEGRATE-HTA. |
| Q52603250 | Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders' Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL). |
| Q33568653 | Appraising the holistic value of Lenvatinib for radio-iodine refractory differentiated thyroid cancer: A multi-country study applying pragmatic MCDA. |
| Q35685387 | Balancing costs and benefits at different stages of medical innovation: a systematic review of Multi-criteria decision analysis (MCDA). |
| Q59130348 | Can reflective multicriteria be the new paradigm for healthcare decision-making? The EVIDEM journey |
| Q39055438 | Eliciting societal preferences of reimbursement decision criteria for anti cancer drugs in South Korea |
| Q47583991 | Health Technology Assessment and Appraisal of Therapies for Rare Diseases. |
| Q92131859 | Hospital staff perspectives towards health technology assessment: data from a multidisciplinary survey |
| Q37297978 | Multi-Criteria Decision Analysis for Assessment and Appraisal of Orphan Drugs. |
| Q90043415 | Multi-criteria decision analysis for health technology assessment: addressing methodological challenges to improve the state of the art |
| Q58078991 | Multicriteria decision analysis (MCDA) in health care: a systematic review of the main characteristics and methodological steps |
| Q37692633 | Recommendations from the European Working Group for Value Assessment and Funding Processes in Rare Diseases (ORPH-VAL). |
Search more.